0000950170-24-064691.txt : 20240524
0000950170-24-064691.hdr.sgml : 20240524
20240524165534
ACCESSION NUMBER: 0000950170-24-064691
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240522
FILED AS OF DATE: 20240524
DATE AS OF CHANGE: 20240524
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WIDDER KENNETH J
CENTRAL INDEX KEY: 0001065168
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
ORGANIZATION NAME: 03 Life Sciences
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36075
FILM NUMBER: 24985266
MAIL ADDRESS:
STREET 1: 10070 BARNES CANYON ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Evoke Pharma Inc
CENTRAL INDEX KEY: 0001403708
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 208447886
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 420 STEVENS AVENUE
STREET 2: SUITE 370
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
BUSINESS PHONE: 858-345-1494
MAIL ADDRESS:
STREET 1: 420 STEVENS AVENUE
STREET 2: SUITE 370
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
4
1
ownership.xml
4
X0508
4
2024-05-22
0001403708
Evoke Pharma Inc
EVOK
0001065168
WIDDER KENNETH J
C/O EVOKE PHARMA, INC.
420 STEVENS AVENUE, SUITE 230
SOLANA BEACH
CA
92075
true
false
false
false
false
Stock Option (Right to Buy)
0.451
2024-05-22
4
A
false
14250
0
A
2034-05-21
Common Stock
14250
14250
D
The total number of shares of common stock subject to the option vests on the one-year anniversary of the date of grant, subject to the Reporting Person's continued service to the Issuer through such vesting date.
/s/ Matthew J. D'Onofrio, Attorney-in-fact for Kenneth J. Widder
2024-05-24